| 2025 |
Mekonnen, L. B., Teo, T., Noll, B., Rahaman, M. H., Lenjisa, J., Basnet, S., . . . Wang, S. (2025). A brain-penetrant CDK4/6 inhibitor - AU3-14 shows robust anti-tumor efficacy against glioblastoma.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 189(118340), 118340.
DOI Europe PMC1 |
| 2024 |
Li, M., Bennett, M. K., Toubia, J., Pope, V. S., Tea, M. N., Tamang, S., . . . Pitson, S. M. (2024). An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma. British Journal of Haematology, 204(2), 566-570.
DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Lewis, A. C., Pope, V. S., Tea, M. N., Li, M., Nwosu, G. O., Nguyen, T. M., . . . Pitson, S. M. (2022). Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.. Blood, 139(26), 3737-3751.
DOI Scopus37 WoS32 Europe PMC35 |
| 2022 |
Gargett, T., Ebert, L. M., Truong, N. T. H., Kollis, P. M., Sedivakova, K., Yu, W., . . . Brown, M. P. (2022). GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for ImmunoTherapy of Cancer, 10(9), 1-15.
DOI Scopus79 WoS79 Europe PMC75 |
| 2021 |
Duszyc, K., Gomez, G. A., Lagendijk, A. K., Yau, M. K., Nanavati, B. N., Gliddon, B. L., . . . Yap, A. S. (2021). Mechanotransduction activates RhoA in the neighbors of apoptotic epithelial cells to engage apical extrusion. Current Biology, 31(6), 1326-1336.
DOI Scopus47 WoS46 Europe PMC47 |
| 2021 |
Bennett, M. K., Li, M., Tea, M. N., Pitman, M. R., Toubia, J., Wang, P. P. -S., . . . Pitson, S. M. (2021). Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition.. Neoplasia, 24(1), 1-11.
DOI Scopus16 WoS16 Europe PMC13 |
| 2019 |
Neubauer, H. A., Tea, M. N., Zebol, J. R., Gliddon, B. L., Stefanidis, C., Moretti, P. A. B., . . . Pitson, S. M. (2019). Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma. Oncogene, 38(8), 1151-1165.
DOI Scopus26 WoS24 Europe PMC18 |
| 2017 |
Zhu, W., Gliddon, B., Jarman, K., Moretti, P., Tin, T., Parise, L., . . . Pitson, S. (2017). CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1. Oncogene, 36(18), 2619-2627.
DOI Scopus29 WoS27 Europe PMC19 |
| 2017 |
Zhu, W., Jarman, K., Lokman, N., Neubauer, H., Davies, L., Gliddon, B., . . . Pitson, S. (2017). CIB2 negatively regulates oncogenic signaling in ovarian cancer via sphingosine kinase 1. Cancer Research, 77(18), 4823-4834.
DOI Scopus30 WoS26 Europe PMC26 |
| 2016 |
Clarke, J., Davies, L., Calvert, J., Gliddon, B., Al Shujari, W., Aloia, A., . . . Carr, J. (2016). Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses. Journal of General Virology, 97(1), 95-109.
DOI Scopus20 WoS17 Europe PMC17 |
| 2016 |
Neubauer, H. A., Pham, D. H., Zebol, J. R., Moretti, P. A. B., Peterson, A. L., Leclercq, T. M., . . . Pitson, S. M. (2016). An oncogenic role for sphingosine kinase 2. Oncotarget, 7(40), 64886-64899.
DOI Scopus54 WoS50 Europe PMC52 |
| 2015 |
Pitman, M., Powell, J., Coolen, C., Moretti, P., Zebol, J., Pham, D., . . . Pitson, S. (2015). A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties. Oncotarget, 6(9), 7065-7083.
DOI Scopus65 WoS64 Europe PMC56 |
| 2015 |
Parham, K., Zebol, J., Tooley, K., Sun, W., Moldenhauer, L., Cockshell, M., . . . Bonder, C. (2015). Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis. The FASEB Journal, 29(9), 3638-3653.
DOI Scopus82 WoS77 Europe PMC70 |
| 2014 |
Pham, D., Powell, J., Gliddon, B., Moretti, P., Tsykin, A., Van der Hoek, M., . . . Pitson, S. (2014). Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1. Oncogene, 33(48), 5559-5568.
DOI Scopus26 WoS25 Europe PMC23 |
| 2013 |
Nguyen, N., Kozer Gorevich, N., Gliddon, B. L., Smolka, A. J., Clayton, A. H., Gleeson, P. A., & van Driel, I. R. (2013). Independent trafficking of the KCNQ1 K+ channel and H+ -K+ -ATPase in gastric parietal cells from mice. American journal of physiology: gastrointestinal and liver physiology, 304(2), 157-166.
DOI Scopus15 Europe PMC12 |
| 2011 |
Gunn, P. A., Gliddon, B. L., Londrigan, S. L., Lew, A. M., van Driel, I. R., & Gleeson, P. A. (2011). The Golgi apparatus in the endomembrane-rich gastric parietal cells exist as functional stable mini-stacks dispersed throughout the cytoplasm. Biology of the cell, 103(12), 559-572.
DOI Scopus16 Europe PMC15 |
| 2011 |
Pitman, M., Barr, R., Gliddon, B., Magarey, A., Moretti, P., & Pitson, S. (2011). A critical role for the protein phosphatase 2A B′α regulatory subunit in dephosphorylation of sphingosine kinase 1. International Journal of Biochemistry & Cell Biology, 43(3), 342-347.
DOI Scopus23 WoS18 Europe PMC20 |
| 2008 |
Gliddon, B. L., Nguyen, N., Gunn, P., Gleeson, P., & Van, D. I. (2008). Isolation, culture and adenoviral transduction of parietal cells from mouse gastric mucosa. Biomedical materials, 3(3), 1-9.
DOI Scopus14 Europe PMC7 |
| 2007 |
Ang, D. K. Y., Brodnicki, T. C., Jordan, M. A., Wilson, W. E., Silveira, P., Gliddon, B. L., . . . van Driel, I. R. (2007). Two genetic loci independently confer susceptibility to autoimmune gastritis. International Immunology, 19(9), 1135-1144.
DOI Scopus17 Europe PMC9 |
| 2006 |
Crawley, A., Gliddon, B., Auclair, D., Brodie, S., Hirte, C., King, B., . . . Hopwood, J. (2006). Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Research, 1104(1), 1-17.
DOI Scopus94 WoS93 Europe PMC87 |
| 2004 |
Gliddon, B., Yogalingam, G., & Hopwood, J. (2004). Purification and characterization of recombinant murine sulfamidase. Molecular Genetics and Metabolism, 83(3), 239-245.
DOI Scopus9 WoS7 Europe PMC5 |
| 2004 |
Gliddon, B., & Hopwood, J. (2004). Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice. Pediatric Research, 56(1), 65-72.
DOI Scopus75 WoS67 Europe PMC60 |
| 2002 |
Yogalingam, G., Pollard, T., Gliddon, B., Jolly, R., & Hopwood, J. (2002). Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs. Genomics, 79(2), 150-153.
DOI Scopus47 WoS38 Europe PMC34 |
| 2001 |
Bhattacharyya, R., Gliddon, B., Beccari, T., Hopwood, J., & Stanley, P. (2001). A novel missense mutation in lysosomal sulfamidase is the basis of MPS III A in a spontaneous mouse mutant. Glycobiology, 11(1), 99-103.
DOI Scopus72 WoS71 Europe PMC64 |
